INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
MS
Musunuri ShankarDirector, Chief Executive Officer
OCGNOcugen, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
57.3K sh
Sep 9, 2026Sep 11, 2026
Page 125 of 481
← PrevNext →
traded Sep 9, 2026
+2d
SEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$344K
640 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$273K
512 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$345K
644 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$280K
520 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$273K
505 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$277K
522 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$558K
1,040 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

5
GC
Gracey CraigChief Accounting Officer
OMDAOmada Health, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
644 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$837K
1,539 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$69K
131 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$87K
160 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$415K
761 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$212K
396 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$371K
687 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$196K
368 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$196K
362 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$184K
347 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$652K
1,202 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$116K
215 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

3
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$7,996
23 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

3
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$9,145
25 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

1
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$117K
218 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

1
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$86K
160 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

1
AT
Arora TarunChief Accounting Officer
RNGRingCentral, Inc.
Open-market sale · 10b5-1 plan
SELL$190K
2,679 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

1
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$66K
120 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

1
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$57K
106 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

1
AT
Arora TarunChief Accounting Officer
RNGRingCentral, Inc.
Open-market sale · 10b5-1 plan
SELL$104K
1,493 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

1
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$199K
368 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

0
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$32K
60 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

0
AL
Azar Samak LChief Legal Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$15K
335 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

51
JS
Jubran SamiEVP Chief Finance Officer
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$55K
1,824 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

48
JS
Jubran SamiEVP Chief Finance Officer
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$36K
1,196 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

44
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3.08M
29.9K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

42
WH
Williams Ashley HDirector
TFSLTFS Financial CORP
Open-market sale
SELL$173K
10.0K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

42
BS
Butcher StephanieSenior Managing Director
IVZInvesco Ltd.
Open-market sale
SELL$1.46M
45.1K sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC Form 4

Evidence

42
MJ
Morais Silvio JoseDirector
STNEStoneCo Ltd.
Open-market sale
SELL$208K
21.0K sh
Sep 2, 2026Sep 10, 2026
traded Sep 2, 2026
+8dSEC Form 4

Evidence

42
PJ
Parish Douglas J.Director
BWBBridgewater Bancshares Inc
Open-market sale
SELL$86K
4,000 sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC Form 4

Evidence

42
SA
Senn AndrewPresident, Growth & Innovation
ITGRInteger Holdings Corp
Open-market sale
SELL$1.19M
9,408 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

41
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$567K
5,468 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K